论文信息 - Challenges of managing sympathetic ophthalmia in a young child and the role of infliximab. - 字舞流文

Challenges of managing sympathetic ophthalmia in a young child and the role of infliximab.

The authors report the difficult challenges and use of infliximab in the delayed presentation of a 2½-year-old boy with a penetrating eye injury from a small ballpoint pen that led to sympathetic ophthalmia.

K. Ziahosseini | W. Newman

[1] K. Yen,et al. Outcome and prognosis of pediatric patients with delayed diagnosis of open-globe injuries. , 2009, Journal of pediatric ophthalmology and strabismus.

[2] S. Saraswathy,et al. Photoreceptor oxidative damage in sympathetic ophthalmia. , 2008, American journal of ophthalmology.

[3] N. Rao. Chapter 106 – Sympathetic Ophthalmia , 2006 .

[4] P. Murray,et al. Anti-TNF-α therapy for uveitis: Behçet and beyond , 2005, Eye.

[5] J. Forrester,et al. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland , 2000, The British journal of ophthalmology.

[6] G. Sussman,et al. Ocular and Systemic Determination of and Tumour Necrosis Factor in a Patient with Ocular Inflammation , 1992 .

[7] D. Albert,et al. Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913--1978). , 1980, Ophthalmology.